Infusion Pumps Market: Prospects for Leading Companies 2015-2025

LONDON, November 18, 2015 /PRNewswire/ --

A Strong Infusion pumps pipeline -Will it have a significant effect on the market?

Visiongain's brand new report shows you potential revenues to 2025, assessing data, trends, opportunities and prospects there.

Included in the report is a lengthy discussion of the strengths and weakness of the field of infusion pumps, as well as the opportunities and threats facing developers. The report includes a forecast of the global infusion pumps market through to 2025, as well as forecasts for three submarkets :

• Insulin pumps
• Enteral feeding pumps
• Other pumps (a grouped category inclusive of chemotherapy pumps and PCA infusion pumps).

Forecasts from 2015-2025 and other analyses show you commercial prospects

This independent, 206-page report guarantees you will remain better informed than your competition. With 128 tables and figures examining the infusion pumps market space, the report gives you a visual, one-stop breakdown of your market. In addition, this report provides analysis of competing technologies, with forecasts to 2025 for the global drug delivery technologies market and the following submarkets:

• Oral drug delivery
• Inhalation drug delivery
• Injectable/implantable drug delivery
• Transdermal drug delivery
• Ocular drug delivery
• Nasal drug delivery

Forecasts from 2015-2025 and other analyses show you commercial prospects
Besides revenue forecasting to 2025, our new study provides you with recent results, growth rates, and market shares. Discover qualitative analyses (including SWOT and Porter's Five Forces analysis), product profiles and commercial developments. Read the full transcript of one exclusive expert opinion interview from an industry specialist informing your understanding and allowing you to assess prospects for investments and sales, including:
• Prof. Charles Clark, Former Associate Dean, Indiana University School of Medicine

Discover how high revenues can go. Our analysis also breaks the main world forecast into geographical markets.

To see a report overview please email Sara Peerun on [email protected]

What are the prospects in the leading regions and countries?
National markets are also discussed, with forecasts to 2025 provided for the US, EU5 (Germany, UK, France, Italy and Spain), Japan, China, India, Brazil, Russia and South Korea.

There will be growth in both developed and developing pharmaceutical markets. Our analyses show that the emerging markets will achieve high revenue growth by 2025.

Potential for market growth
Overall world revenue for infusion pumps will reach $8.09bn in 2015, our work forecasts. We predict strong revenue growth through to 2025. Market entry of novel therapies, increasing conversion from conventional methods for insulin delivery to the use of insulin infusion pumps, and a shift towards homecare will drive sales until 2025.
• Discover capabilities, progress, and commercial prospects, helping you stay ahead.
• Research and development - assess innovation, trends and possibilities
• What about R&D? In this report you will find analyses for a number of pipeline pumps and novel technologies.
• Advanced infusion pumps are in great demand, allowing patients safer and more reliable treatments. Our work explains, discussing many issues.

How does Infusion Pumps Market: Prospects for Leading Companies 2015-2025 report help you?
In summary, our 206 pages report gives you the following knowledge:
• A comprehensive introduction to infusion pumps - discover everything you need to know about their use
• Revenue forecasts to 2025 for the leading national markets
• Review of R&D pipelines - investigate developmental trends and progress
• Discussion of what stimulates and restrains companies and the market
• Prospects for established firms and those seeking to enter the market
• View an exclusive interview transcript

You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.

Visiongain's study is for everybody needing commercial analyses for the Infusion Pumps market and leading companies. You will find data, trends and predictions. Please order our report now.

To see a report overview please email Sara Peerun on [email protected]

To request an exec summary of this report please email Sara Peerun at [email protected] or call Tel: +44(0)20-7336-6100

Or click on https://www.visiongain.com/Report/1522/Infusion-Pumps-Market-Prospects-for-Leading-Companies-2015-2025

Companies Listed

Abbott Nutrition
Akas Medical
Alcor Scientific
Alkermes
Allied Medical
Altea Therapeutics
Amsino International
Animas Corporation
Aradigm
Asante
B. Braun
Baxter
Bayer Healthcare
Becton & Dickson & Co
Bio-Med
BMS
Boston Scientific Corporation
Calibra Medical
Cardinal Health
CareFusion
Celgene
Cellnovo
Celsus Laboratories
CeQur
CME Medical
Codman and Shurtleff
Conmed Corporation
Cook Medical
Covidien
D. Medical Industries
Danone Nutricia
Debiotech
DePuy
Disetronic Medical Systems
DreaMed Diabetes
Eli Lilly
Emco
Emisphere
Fresenius Kabi
GE Medical
Generex Biotechnology Corporation
Glycologic
Hanraj Nayyar Medical India
Hospira
IBM
I-Flow
Insulet Corporation
Intercell
Johnson and Johnson
Kimberly Clark Corporation
Medingo
Medsolve Technologies
Medtronic
Micrel Medical Devices
Mindray
Moog
NeoDevices
NeoMed
Nestle Healthcare
NiliMEDIX
Novartis
Noven Pharmaceuticals
NovoNordisk
Pacira Pharmaceuticals
Philips Medical
pSivida Corporation
Q Core Medical
Roche
Sanofi
Schiller
Smith Medical
SOOIL
Symbios Medical Products
Takeda
Tandem Diabetics Care
Tandem Diagnostics
Terumo Medical Corporation
Trivitron
Valeritas
Vectura
Vishal Surgical
WalkMed Inc
Zevex

Other Organisations Mentioned in this Report

Agência Nacional de Vigilância Sanitária (ANVISA)
American Medical Devices and Diagnostic Association (AMDD)
Center for Devices and Radiological Health (CDRH)
Centres for Medicare and Medicaid Service (CMS)
China Food and Drug Administration (CFDA)
China's National Health and Planning Commission (NHPC)
Chinese Ministry of Science and Technology
Government Accountability Office (GAO)
Indiana University School of Medicine
Japanese Ministry of Health, Labour and Welfare (MHLW)
Juvenile Diabetes Research Foundation
Medical Devices Information & Technology Assistance Centre (MDITAC)
Medicines and Healthcare products Regulatory Agency (MHRA)
National Competent Authorities (NCAs)
National Diabetes Education Program (NDEP)
National Institute for Health and Clinical Excellence (NICE)
National Medical Devices Authority (NMDA)
NHS England
Ningbo First Hospital
Roszdravnadzor
Sahlgrenska Academy
Servicio Sanitario Nazionale (SSN)
South Korean Ministry for Food and Drug Safety (MFDS)
South Korean Ministry of Health and Welfare (MOHW)
South Korean Ministry of Science, ICT and Future Planning (MSIP)
South Korean Ministry of Trade, Industry and Energy (MOTIE)
Único de Saúde (SUS)
United Nations Population Division
United States Food and Drug Administration (FDA)
US Department of Health and Human Services
World Bank
World Health Organization (WHO)
Zhejiang Hospital

To see a report overview please email Sara Peerun on [email protected]

SOURCE Visiongain